<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Data Brief</journal-id><journal-id journal-id-type="iso-abbrev">Data Brief</journal-id><journal-title-group><journal-title>Data in Brief</journal-title></journal-title-group><issn pub-type="epub">2352-3409</issn><publisher><publisher-name>Elsevier</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">26958635</article-id><article-id pub-id-type="pmc">4764771</article-id><article-id pub-id-type="publisher-id">S2352-3409(16)30031-2</article-id><article-id pub-id-type="doi">10.1016/j.dib.2016.02.009</article-id><article-categories><subj-group subj-group-type="heading"><subject>Data Article</subject></subj-group></article-categories><title-group><article-title>Data on interaction between adeno-associated virus and U87 cell via cRGD chemical modification</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Chuanling</given-names></name></contrib><contrib contrib-type="author"><name><surname>Yao</surname><given-names>Tianzhuo</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zheng</surname><given-names>Yongxiang</given-names></name></contrib><contrib contrib-type="author"><name><surname>Li</surname><given-names>Zhongjun</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Lihe</given-names></name></contrib><contrib contrib-type="author"><name><surname>Zhou</surname><given-names>Demin</given-names></name><email>deminzhou@bjmu.edu.cn</email><xref rid="cor1" ref-type="corresp">&#x0204e;</xref></contrib></contrib-group><aff id="aff0005">State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, No. 38, Xueyuan Road, Beijing 100191, China</aff><author-notes><corresp id="cor1"><label>&#x0204e;</label>Corresponding author. Tel.: +86 10 8280 5857; fax: +86 10 8280 5519. <email>deminzhou@bjmu.edu.cn</email></corresp></author-notes><pub-date pub-type="pmc-release"><day>10</day><month>2</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on <pub-date
						pub-type="epub">.--><pub-date pub-type="collection"><month>6</month><year>2016</year></pub-date><pub-date pub-type="epub"><day>10</day><month>2</month><year>2016</year></pub-date><volume>7</volume><fpage>77</fpage><lpage>80</lpage><history><date date-type="received"><day>8</day><month>12</month><year>2015</year></date><date date-type="rev-recd"><day>18</day><month>1</month><year>2016</year></date><date date-type="accepted"><day>2</day><month>2</month><year>2016</year></date></history><permissions><copyright-statement>&#x000a9; 2016 Published by Elsevier Inc.</copyright-statement><copyright-year>2016</copyright-year><copyright-holder/><license license-type="CC BY" xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).</license-p></license></permissions><abstract><p>RGD tripeptide is a specific, high-affinity ligand for integrin, which is highly expressed in cancer cells. We previously reported that cRGD chemically modified AAV2 (AAV2<sup>N587+1/azido+RGD</sup>) showed significantly enhanced infectivity compared to RGD genetically inserted AAV2 (AAV2<sup>N587+RGD</sup>) (10.1016/j.biomaterials.2015.11.066) <xref rid="bib1" ref-type="bibr">[1]</xref>. Herein we provide the binding ability analysis of RGD modified AAV2 and U87 cell by flow cytometry and the theoretical working model of RGD&#x02013;&#x003b1;v&#x003b2;3 integrin interaction.</p></abstract><kwd-group><title>Keywords</title><kwd>Adeno-associated virus</kwd><kwd>Viral modification</kwd><kwd>Targeted gene delivery</kwd></kwd-group></article-meta></front><body><sec id="s0005"><label>1</label><title><bold>Specifications table</bold></title><p><table-wrap id="t0005" position="float"><alt-text id="at0015">Table</alt-text><table frame="hsides" rules="groups"><tbody><tr><td>Subject area</td><td><italic>Biology, Chemistry</italic></td></tr><tr><td>More specific subject area</td><td><italic>Gene therapy</italic></td></tr><tr><td>Type of data</td><td><italic>Figure</italic></td></tr><tr><td>How data was acquired</td><td><italic>Flow cytometry</italic></td></tr><tr><td>Data format</td><td><italic>Analyzed</italic></td></tr><tr><td>Experimental factors</td><td><italic>Site-specific modification of AAV2 with cRGD</italic></td></tr><tr><td>Experimental features</td><td><italic>Binding ability between AAV2 and U87 was analyzed by Flow Cytometry</italic></td></tr><tr><td>Data source location</td><td><italic>Peking University, Beijing, China</italic></td></tr><tr><td>Data accessibility</td><td><italic>Data is within this article and at Protein data bank PDB: 1L5G, PDB: 1LP3</italic></td></tr></tbody></table></table-wrap></p></sec><sec id="s0010"><label>2</label><title>Value of the data</title><p><list list-type="simple"><list-item id="u0005"><label>&#x02022;</label><p>This data set will be of value to the scientific community wanting to analyze the binding ability of virus and host cell.</p></list-item><list-item id="u0010"><label>&#x02022;</label><p>The data show new way to study the biological mechanisms of AAV2 entry.</p></list-item><list-item id="u0015"><label>&#x02022;</label><p>The data may stimulate further research on viral targeted gene delivery.</p></list-item></list></p></sec><sec id="s0015"><label>3</label><title><bold>Data</bold></title><p>The data shared in this article is the experimental and theoretical analysis of interaction between cRGD modified AAV2 and host cell (U87).</p></sec><sec id="s0020"><label>4</label><title>Experimental design, materials and methods</title><sec id="s0025"><label>4.1</label><title>Cell lines</title><p>U87 cells were maintained in an atmosphere containing 5% CO<sub>2</sub> in Dulbecco&#x02019;s modified Eagle&#x02019;s medium (Gibco, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS; PAA, Austria) and 2&#x000a0;mM <sc>l</sc>-glutamine (Gibco).</p></sec><sec id="s0030"><label>4.2</label><title>Cell surface binding assays</title><p>Cells were resuspended at a density of 2&#x000d7;10<sup>6</sup>&#x000a0;cells/mL in binding buffer containing 5% FBS. Equal amounts of viral vectors were incubated with cells at 4&#x000a0;&#x000b0;C for 2&#x000a0;h, and unbound vector particles were then removed by washing with PBS. Vector particles bound to HeLa or U87 cells were detected by staining with anti-AAV A20 monoclonal antibodies and subsequent FACS analysis. *<italic>P</italic>&#x0003c;0.05 versus the corresponding control (<xref rid="f0005" ref-type="fig">Fig. 1</xref>, <xref rid="f0010" ref-type="fig">Fig. 2</xref>).</p></sec></sec></body><back><ref-list><title>References</title><ref id="bib1"><label>1</label><mixed-citation publication-type="other" id="othref3006">C. Zhang, T. Yao, Y. Zheng, Z. Li, L. Zhang and D. Zhou, Development of next generation of adeno-associated viral vectors via precision engineering for preferable selective tropism and efficient gene delivery, Biomaterials. 80 (2016) 134&#x02013;145, <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.biomaterials.2015.11.066" id="ir1235">10.1016/j.biomaterials.2015.11.066</ext-link>.</mixed-citation></ref><ref id="bib2"><label>2</label><element-citation publication-type="journal" id="sbref2"><person-group person-group-type="author"><name><surname>Xiong</surname><given-names>J.P.</given-names></name><name><surname>Stehle</surname><given-names>T.</given-names></name><name><surname>Zhang</surname><given-names>R.</given-names></name><name><surname>Joachimiak</surname><given-names>A.</given-names></name><name><surname>Frech</surname><given-names>M.</given-names></name><name><surname>Goodman</surname><given-names>S.L.</given-names></name></person-group><article-title>Crystal structure of the extracellular segment of integrin alpha Vbeta3 in complex with an Arg&#x02013;Gly&#x02013;Asp ligand</article-title><source>Science</source><volume>296</volume><issue>5565</issue><year>2002</year><fpage>151</fpage><lpage>155</lpage><pub-id pub-id-type="pmid">11884718</pub-id></element-citation></ref><ref id="bib3"><label>3</label><element-citation publication-type="journal" id="sbref3"><person-group person-group-type="author"><name><surname>Gottschalk</surname><given-names>K.E.</given-names></name><name><surname>Kessler</surname><given-names>H.</given-names></name></person-group><article-title>A computational model of transmembrane integrin clustering</article-title><source>Structure</source><volume>12</volume><issue>6</issue><year>2004</year><fpage>1109</fpage><lpage>1116</lpage><pub-id pub-id-type="pmid">15274930</pub-id></element-citation></ref><ref id="bib4"><label>4</label><element-citation publication-type="journal" id="sbref4"><person-group person-group-type="author"><name><surname>Xie</surname><given-names>Q.</given-names></name><name><surname>Bu</surname><given-names>W.</given-names></name><name><surname>Bhatia</surname><given-names>S.</given-names></name><name><surname>Hare</surname><given-names>J.</given-names></name><name><surname>Somasundaram</surname><given-names>T.</given-names></name><name><surname>Azzi</surname><given-names>A.</given-names></name></person-group><article-title>The atomic structure of adeno-associated virus (AAV-2), a vector for human gene therapy</article-title><source>Proc. Natl. Acad. Sci. USA</source><volume>99</volume><issue>16</issue><year>2002</year><fpage>10405</fpage><lpage>10410</lpage><pub-id pub-id-type="pmid">12136130</pub-id></element-citation></ref></ref-list><sec id="s0045" sec-type="supplementary-material"><label>Appendix A</label><title>Supplementary material</title><p><supplementary-material content-type="local-data" id="ec0005"><caption><p>Supplementary material</p></caption><media xlink:href="mmc1.pdf"/></supplementary-material></p></sec><ack id="ack0005"><title>Acknowledgments</title><p>We thank Drs. Qihua He, Bo Xu (Peking University) and Meng Lai (PerkinElmer) for their assistance with the single virus tracking experiment and Dr. Jinmin Zhou for assistance with viral purification. This work was supported by the <funding-source id="gs1">National Basic Research Program of China</funding-source> (973 Program; Grant no. 2010CB12300), the <funding-source id="gs2">National Natural Science Foundation of China</funding-source> (Grant nos. 31200568, 81530090), the <funding-source id="gs3">Research Fund for the Doctoral Program of Higher Education of China</funding-source> (RFDP, Grant no. 20110001120037), and the <funding-source id="gs4">Beijing Natural Science Foundation</funding-source> (Grant no. 7153170).</p></ack><fn-group><fn id="s0040" fn-type="supplementary-material"><label>Appendix A</label><p>Supplementary data associated with this article can be found in the online version at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.dib.2016.02.009" id="ir0005">10.1016/j.dib.2016.02.009</ext-link>.</p></fn></fn-group></back><floats-group><fig id="f0005"><label>Fig. 1</label><caption><p>Analysis of the binding ability of vector particles with HeLa and U87 cells.</p></caption><alt-text id="at0005">Fig. 1</alt-text><graphic xlink:href="gr1"/></fig><fig id="f0010"><label>Fig. 2</label><caption><p>Theoretical analysis of the different effects of RGD tethering versus RGD fusion on improvement of tropism selectivity <xref rid="bib2" ref-type="bibr">[2]</xref>, <xref rid="bib3" ref-type="bibr">[3]</xref>, <xref rid="bib4" ref-type="bibr">[4]</xref>. (A) The three-dimensional model of &#x003b1;v&#x003b2;3 receptor clustering. The distance between clustering &#x003b1;v&#x003b2;3 molecules for RGD binding was labeled accordingly. Black arrows indicate RGD binding sites. (B) Schematic representative of the structure of RGD tethering versus RGD fusion to the AAV capsid protein at site N587+1. The distance between the two adjacent sites of RGD fused on AAV2 was 37.52&#x000a0;&#x000c5;. The length of DIBO-cRGD was 43.41&#x000a0;&#x000c5;. Upon tethering of cRGD via a DIBO linker, the maximum distance between two cRGD on AAV2<sup>N587+1/NAEK+RGD</sup> increased to 124.34&#x000a0;&#x000c5; (2&#x000d7;43.41&#x000a0;&#x000c5;+37.52&#x000a0;&#x000c5;=124.34&#x000a0;&#x000c5;). (C) Schematic illustration of the interactions between the clustering &#x003b1;v&#x003b2;3 receptor and adjacent RGD-tethered versus RGD-fused ligands within the AAV2 vector. The distance between two adjacent RGD fusion motifs (~37.52&#x000a0;&#x000c5;) was much shorter than the distance between the clustering &#x003b1;v&#x003b2;3 binding sites (either 65.78 or 41.92&#x000a0;&#x000c5;), preventing simultaneous binding. In contrast, the distance between the two adjacent tethered RGD motifs on AAV2<sup>N587+1/NAEK+RGD</sup> was 124.34&#x000a0;&#x000c5;, allowing simultaneous binding of multiple integrin &#x003b1;v&#x003b2;3 receptors. Blue indicates the RGD motifs. (For interpretation of the references to color in this figure legend, the reader is referred to the web version of this article.)</p></caption><alt-text id="at0010">Fig. 2</alt-text><graphic xlink:href="gr2"/></fig></floats-group></article>